CVS Health and Medable will collaborate to make clinical trials more accessible for patients, the firms said Monday.
Under terms of the pact, patents at select CVS Health’s MinuteClinic locations will get expanded clinical trial access and engagement via Medable’s trials software platform. CVS Health’s clinical trial services arm will manage the relationship.
The collaboration intends to “build greater trust in health and medicine,” said Medable chief growth officer Sans Thakur.
Only a small fraction of Americans participate in clinical studies. Many subjects drop out before study completion, and the majority do not meet enrollment deadlines. Moreover, Asian, Hispanic and Latino groups continue to be significantly and consistently underrepresented, the firms noted.
Medable’s software will be used to capture endpoint data and other information both on-site and remotely. CVS Health will leverage its analytics and community reach to help with patient recruitment, as well as assign certain MinuteClinics to deliver Phase III/IV trials and real-world evidence studies of devices and therapeutics.
Decentralized options for studies may also include using CVS Health’s Coram health services team, either at home or virtually.
